Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK949E (Quetiapine XR) in MDD with Inadequate Response
NCT01725282Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in major depressive disorder (MDD), sponsored by Astellas Pharma. Started Dec 2011; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01725282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725282.